Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylamide SCHEMBL205957 | 0.89 | CHRM2 (0.38) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL27545231 | 0.87 | CHRM1 (0.50) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL16429852 | 0.87 | DNM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL16429854 | 0.87 | DNM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL16429931 | 0.87 | DNM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL16429738 | 0.87 | DNM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL127031 | 0.85 | CHRM1 (0.48) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL28055236 | 0.84 | CHRM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| Ammonia Solution, Strong SCHEMBL28118760 | 0.84 | CHRM1 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRNB2 | |
| SCHEMBL5604791 | 0.84 | DNM1 (0.50) | CHRM1CHRM2CHRM4CHRM5CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4265326-A2 | MICROCAPSULES COMPRISING NATURAL MATERIALS | TRuCapSol, LLC. (US) | 2023-10-25 | — | — | EP | claimed |
| US-11794161-B1 | Reduced permeability microcapsules | TRUCAPSOL, LLC (US) | 2023-10-24 | — | — | US | claimed |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | ALTER DOMUS (US) LLC | 2023-10-19 | — | — | US | claimed |
| US-11571674-B1 | Environmentally biodegradable microcapsules | TRUCAPSOL LLC (US) | 2023-02-07 | — | — | US | claimed |
| US-20220133603-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | ALTER DOMUS (US) LLC | 2022-05-05 | — | — | US | claimed |
| US-20210237019-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | TRUCAPSOL LLC (US) | 2021-08-05 | — | — | US | claimed |
| US-20210237018-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | TRUCAPSOL LLC (US) | 2021-08-05 | — | — | US | claimed |
| US-11007501-B2 | Reduced permeability microcapsules | TRUCAPSOL LLC (US) | 2021-05-18 | — | — | US | claimed |
| WO-2019173062-A1 | REDUCED PERMEABILITY MICROCAPSULES | TRUCAPSOL, LLC (US) | 2019-09-12 | — | — | WO | claimed |
| US-20190275490-A1 | REDUCED PERMEABILITY MICROCAPSULES | ALTER DOMUS (US) LLC | 2019-09-12 | — | — | US | claimed |
| US-7021380-B2 | Compositions comprising set retarder compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. (US) | 2006-04-04 | — | — | US | claimed |
| WO-2006005904-A1 | COMPOSITIONS COMPRISING SET RETARDER COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2006-01-19 | — | — | WO | claimed |
| US-20050033251-A1 | Microbiocides; coating to gauze -type wound dressing | QUICK-MED TECHNOLOGIES, INC. (US) | 2005-02-10 | — | — | US | claimed |
| US-20040262001-A1 | Compositions comprising set retarder compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2004-12-30 | — | — | US | claimed |
| EP-1450966-A2 | ABSORBENT MATERIALS WITH COVALENTLY-BONDED, NONLEACHABLE, POLYMERIC ANTIMICROBIAL SURFACES, AND METHODS FOR PREPARATION | Quick Med Technologies, Inc. (US) | 2004-09-01 | — | — | EP | claimed |
| WO-2003039602-A2 | ABSORBENT MATERIALS WITH COVALENTLY-BONDED, NONLEACHABLE, POLYMERIC ANTIMICROBIAL SURFACES, AND METHODS FOR PREPARATION | QUICK MED TECHNOLOGIES, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| US-20020177828-A1 | Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation | PHRONESIS PARTNERS, L.P. | 2002-11-28 | — | — | US | claimed |
| EP-0441911-B1 | ANTI-STATIC VARNISH COMPOSITIONS | SUN CHEMICAL CORP (US) | 1995-05-03 | — | — | EP | claimed |
| US-4964916-A | Anti-static varnish compositions | SUN CHEMICAL CORPORATION (US) | 1990-10-23 | — | — | US | claimed |
| US-4931522-A | Copolymers of polyalkylene glycol acrylate and a salt of a quarternized acrylate | SUN CHEMICAL CORPORATION, 222 BRIDGE PLAZA SOUTH, FORT LEE, NJ 07024 | 1990-06-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210237018-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | MCM3, MAST3, EPM2A | CHRM1 316/4885CHRM2 268/4885CHRM4 426/4885 |
| US-20220133603-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | SAMM50, FHIT, TNF | CHRM1 565/4885CHRM2 742/4885CHRM4 550/4885 |
| US-20190275490-A1 | REDUCED PERMEABILITY MICROCAPSULES | ABCC1, CHMP4B, SLC18A1 | CHRM1 157/4885CHRM2 177/4885CHRM4 346/4885 |
| US-11007501-B2 | Reduced permeability microcapsules | ABCC1, CHMP4B, SLC18A1 | CHRM1 157/4885CHRM2 177/4885CHRM4 346/4885 |
| US-20210237019-A1 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | MCM3, MAST3, EPM2A | CHRM1 316/4885CHRM2 268/4885CHRM4 426/4885 |
| US-11794161-B1 | Reduced permeability microcapsules | CHMP4B, NSF, ACR | CHRM1 46/4885CHRM2 25/4885CHRM4 28/4885 |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | RCC1, SAMM50, LIPA | CHRM1 1154/4885CHRM2 893/4885CHRM4 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.